Multimorbidity is common and associated with adverse outcomes in heart failure (HF). However, its prognostic value across frailty states is uncertain, particularly whether comorbidities continue to stratify risk once frailty develops.
To evaluate whether frailty modifies the association of multimorbidity i...
V. Copeland, B. Fishman, S. Elimelech et al.· European Heart Journal· 0 citations
Frailty is a multidimensional syndrome of reduced physiologic reserve associated with adverse outcomes in heart failure (HF). Whether its underlying drivers and prognostic significance differ by age remains poorly understood.
To assess age-specific correlations of frailty, predictors of incident frailty, a...
V. Copeland, B. Fishman, S. Elimelech et al.· European Heart Journal· 0 citations
In patients with heart failure and advanced chronic kidney disease, CCBs use was associated with improved survival, supporting their potential role as a safe adjunctive therapy for blood pressure control in this high-risk population.
V. Copeland, A. Milwidsky, S. Elimeleh et al.· American Journal of Medicine· 0 citations
In asymptomatic adults without structural heart disease, the clinical determinants and long-term prognostic trajectories of ectopy exhibit a profound chamber-specific divergence and stands out as a powerful, independent marker of intrinsic electrical vulnerability and long-term cardiovascular risk.
A. Moses, Rotem Givoli Vilensky, N. Makmal et al.· European Heart Journal Open· 0 citations
Frailty fundamentally attenuates risk in HF, while multimorbidity stratifies prognosis only when physiological reserve is preserved, while multimorbidity stratifies prognosis only when physiological reserve is preserved.
V. Copeland, Boris Fishman, S. Elimeleh et al.· Mayo Clinic proceedings· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.